Gastric siderosis: Patterns and significance

American Journal of Surgical Pathology

Volumn 30, Issue 4, 2006, Pages 514-520

  Marginean, Esmeralda C ^a   Bennick, Michael ^a   Cyczk, Jan ^a   Robert, Marie E ^a   Jain, Dhanpat ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fundic glands; Hemochromatosis; Iron deposition; Stomach

Indexed keywords

FERRIC FERROCYANIDE; FERROUS SULFATE; IRON; NONSTEROID ANTIINFLAMMATORY AGENT;

ALCOHOLISM; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDOTHELIUM CELL; FIBROBLAST; GASTRITIS; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HEMOCHROMATOSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INFLAMMATION; IRON OVERLOAD; MACROPHAGE; PREVALENCE; RARE DISEASE; SIDEROSIS; STAINING; STOMACH ANTRUM; STOMACH BIOPSY; STOMACH DISEASE; STOMACH EPITHELIUM; STOMACH FUNDUS; STOMACH SIDEROSIS; STOMACH ULCER; STROMA CELL; BIOPSY; HISTOCHEMISTRY; ISOLATION AND PURIFICATION; LIVER; METABOLISM; PATHOLOGY; RETROSPECTIVE STUDY; ULTRASTRUCTURE;

BIOPSY; GASTRIC FUNDUS; HEMOCHROMATOSIS; HUMANS; IRON; LIVER; PRUSSIAN BLUE REACTION; PYLORIC ANTRUM; RETROSPECTIVE STUDIES; SIDEROSIS; STOMACH DISEASES; STROMAL CELLS;

EID: 33646703998     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000478-200604000-00013     Document Type: Article

References (13)

1. Abraham SC, Yardley JH, Wu TT. Erosive injury to the upper gastrointestinal tract in patients receiving iron medication. Am J Surg Path. 1999;23:1241-1247.
2. Astaldi G, Meardi G, Lisino T. The iron content of jejunal mucoasa obtained by Crosby's biopsy in hemochromatosis and hemosiderosis. Blood. 1966;28:70-82.
3. Astaldi G, Taverna P, Meardi G, et al. Iron content of Brunner's glands in acquired hemochromatosis. Am J Dig Dis. 1968;13:935-939.
4. Conte D, Velio P, Brunelli L, et al. Stainable iron in gastric and duodenal mucosa of primary hemochromatosis patients and alcoholics. Am J Gastroenterol. 1987;82:237-240.
5. Eckstein RP, Symons P. Iron tablets cause histopathologically distinctive lesions in mucosal biopsies of the stomach and esophagus. Pathology. 1996;28:142-145.
6. Fodinger M, Sundere-Plassmann G. Low clinical penetrance of homozygosity for HFE C282Y: implications for genetic testing? Eur J Clin Invest. 2003;33:737-739.
7. Fracanzani AL, Fargion S, Romano A, et al. Immunohistochemical evidence for a lack of ferritin in duodenal absorptive epithelial cells in idiopathic hemochromatosis. Gastroenterology. 1989;96:1071-1078.
8. Hattori H. High prevalence of hemosiderin accumulation in the cytoplasm of gastric glands in patients with cirrhosis. J Clin Pathol. 2004;57:621-624.
9. Parkkila S, Waheed A, Britton RS, et al. Immunohistochemistry of HLA-H, the protein defective in patients with hereditary hemochromatosis, reveals unique pattern of expression in gastrointestinal tract. Proc Natl Acad Sci USA. 1997;94:2534-2539.
10. Pietrangelo A. Non HFE hemochromatosis. Hepatology. 2004;39:21-29.
11. Pietrangelo A. Physiology of iron transport and the hemochromatosis gene. J Physiol Gastrointest Liver Physiol. 2002;282:G403-G414.
12. Steinberg KK, Cogswell ME, Chang JC, et al. Prevalence of C282Y and H63D mutations in the hemochromatosis (HFE) gene in the United States. JAMA. 2001;285:2216-2222.
13. Zeuzem S. Gut-liver axis. Int J Colorectal Dis. 2000;15:59-82.